Nachrichten zur Pfizer Inc. Aktie

Pfizer’s Bourla Bets His Pension on Company Stock as CEO Defends Drug Firm

…

Antiemetics Drugs Market Size Projected to Surge USD 5.4 Billion Growth by 2032, Exhibit a CAGR of 5.9%

Antiemetics drugs market size from USD 3.1 billion in 2022 to USD 5.4 billion in 10 years. The rising prevalence…

Im Passing on Pfizer Stock in 2024. Heres Why.

…

Im Passing on Pfizer Stock in 2024. Heres Why.

Pfizers best days might be behind it as demand for its COVID-19 products hits a wall.…

[Latest] Global Bone and Joint Health Supplement Market Size/Share Worth USD 17.17 Billion by 2032 at a 9.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…

2 Red Flags That Could Sink Pfizer in 2024

Pfizer shares dropped more than 40% last year.…

Pfizer Is Part Of The 2024 Healthcare Sector Rally Cohort

…

Global $67B+ Womens Health Market Landscape 2024-2030: Analysis by Age, Application and Region

Dublin, Jan. 11, 2024 (GLOBE NEWSWIRE) -- The "Global Womens Health Market Size, Share & Trends Analysis Report…

AstraZeneca: Rebound in 2024 With Double-Digit Earnings Growth

Stocks Analysis by MarketBeat.com (Kate Stalter) covering: Eli Lilly and Company, Merck & Company Inc, Pfizer Inc, Bristol-Myers Squibb Company.…

2 Low-Priced Gene Therapy Stocks to Speculate On

Stocks Analysis by MarketBeat.com (Jea Yu) covering: Novartis AG, Vertex Pharmaceuticals Inc, Biogen Inc, Pfizer Inc. Read MarketBeat.com (Jea Yu)s…

Biontech legt Fokus auf Krebsgeschäft - Erste Mittel sollen 2026 auf den Markt

Frankfurt (Reuters) - Nach dem Ende des Corona-Booms setzt Biontech in den kommenden Jahren verstärkt auf seine Krebsforschung.

"Aktuell laufen…

Pfizer, Genmab cancer therapy under FDA priority review for full approval

…

Will Pfizers Stock Bounce Back in 2024?

The stock looks cheap, but it does come with risks.…

Will Pfizers Stock Bounce Back in 2024? @themotleyfool #stocks $PFE

The stock looks cheap, but it does come with risks.…

Bile Duct Cancer Treatment Market Trends and Forecast 2031 - Market Set for Significant Growth by 2031 Amid Rising Incidences and Technological Advancements

Dublin, Jan. 09, 2024 (GLOBE NEWSWIRE) -- The "Bile Duct Cancer Treatment Market - Global Industry Analysis, Size,…

Pfizer Inc. (PFE) J.P. Morgan 42nd Annual Healthcare Conference (Transcript)

…

Bear of the Day: Pfizer (PFE)

Negative earnings estimate revisions from analysts and weakening sales post-pandemic paint a challenging picture for the companys shares in the…

Opening Bell: Boeing-Aktie belastet Dow Jones; Bitcoin, Coinbase, Unitedhealth, Boeing, Pfizer, Nvidia, Enphase im Fokus

An den US-Börsen zeichnet sich ein uneinheitlicher Wochenauftakt ab. Der Dow Jones startet rund 120 Punkte niedriger in den Handelstag,…

Pfizer: 50% Down From The Highs, Generous Dividend, And Robust Balance Sheet

…

Pfizer: Paying Too Much To Boost Revenues

…

Pfizer: TD Cowen stuft die Aktie herab - Aktienanalyse

New York (www.aktiencheck.de) - Pfizer-Aktienanalyse von TD Cowen: Die Analysten von TD Cowen stufen die Aktie von Pfizer Inc. (ISIN: US7170811035,…

Pfizer and Illumina downgraded but Merck can deliver, declares TD Cowen By Investing.com

Pfizer and Illumina downgraded but Merck can deliver, declares TD Cowen…

Global Pharmaceuticals Market Analysis and Forecast to 2027, with Company Profiles of Key Market Players Bayer, Novartis ,Pfizer and Johnson & Johnson

Dublin, Jan. 04, 2024 (GLOBE NEWSWIRE) -- The "Global Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027"…

Pfizer shares downgraded as patent expirations loom

…

5 Powerhouse Stocks to Fuel Your 2024 Portfolio

Stocks Analysis by Investing.com (Ismael De La Cruz) covering: Gilead Sciences Inc, Amazon.com Inc, Pfizer Inc, Berkshire Hathaway B. Read…

Bayer, Longboard Pharmaceuticals, MorphoSys, Pfizer - welche Aktie Investoren in Kürze suchen

Der Jahresstart 2024 kann sich sehen lassen, sofern man sprichwörtlich auf das richtige Pferd gesetzt hat. Longboard Pharmaceuticals überraschte die…

Pfizer: If You Missed The Pandemic Entry, Heres Another Chance

…

Pure Storage, Pfizer, Southern First Bancshares

U.S. stock indexes fell on Wednesday, as investors locked in profits after a strong 2023 and awaited the Federal Reserves…

Bayer, Defence Therapeutics, Pfizer - anschnallen für den Rebound

Sobald das Jahresende naht, beginnt der versierte Aktieninvestor die Steueroptimierung seines Aktienportfolios. In dieser Zeit sind Anleger besonders darauf bedacht,…

FDA approves updated COVID vaccines from Pfizer, Moderna

…

How To Earn $500 A Month From Pfizer Stock

…

Hier winkt Rendite: Die BioTech-Favoriten für 2024! BioNTech, Pfizer, Cardiol Therapeutics und MorphoSys im Fokus

Für Investoren im BioTech-Sektor war das auslaufende Jahr ein Desaster - kein goldgeränderter Scheck wie sonst so oft. Dennoch: Der…

Drugmakers set to raise U.S. prices on at least 500 drugs in January

Drugmakers including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the United States on more than 500 unique…

wikifolio whispers a.m. Pfizer, Nvidia, Baidu ...

Pfizer 0.19% MuffinTrader (MUF2N): https://www.linkedin.com/posts/patrick-oster-8678a918a_tiktok-muffin-activity-7146267423262785536-_ygZ?utm_source=share&utm_medium=member_desktop (28.12. 23:35) >...…

Could Pfizer Be a No-Brainer Stock to Buy Right Now, Even If Its COVID Sales Continue to Plunge?

…

Could Pfizer Be a No-Brainer Stock to Buy Right Now, Even If Its COVID Sales Continue to Plunge?

COVID-19 products Comirnaty and Paxlovid are no longer Pfizers crown jewels. But thats OK.…

Could Pfizer Be a No-Brainer Stock to Buy Right Now, Even If Its COVID Sales Continue to Plunge? @themotleyfool #stocks $PFE

COVID-19 products Comirnaty and Paxlovid are no longer Pfizers crown jewels. But thats OK.…

dpa-AFX ProFeed